📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatment. (2019)

First Author: Pido-Lopez J

Attributed to: Targeting the innate immune system in Huntington's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-43627-3

PubMed Identifier: 31076648

Publication URI: http://europepmc.org/abstract/MED/31076648

Type: Journal Article/Review

Volume: 9

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322